Cocaine Use Disorder and Cortical Dopamine

Completed · Early Phase 1

Conditions studied: Cocaine Dependence

In brief

The goal of this study is to use \[C-11\]FLB 457 and amphetamine (oral, 0.5 mg/kg) to measure cortical dopamine transmission in cocaine dependent individuals and healthy controls

Key facts

Study ID

NCT03349606

Run by

University of Pittsburgh

People needed

30

Starts

2010-06-02

Expected to finish

2020-06-01

Last updated by the study team

2020-06-04

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

Where it is running

• University of PIttsburgh PET Facility — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.